Sort
25,944 grants matching “neurodegeneration”
A New Technique for Chemical Imaging of Model Neurons
$201,200Illinois State University · R15 · FY2005 · NS
Lysosomal stress triggers exosome release and transfer of proteins
$201,200Ho Wh Yu · Columbia University Health Sciences · R21 · FY2017 · NS
Vector-based models of substantia nigra degeneration
$201,188Louisiana State Univ Hsc Shreveport · R01 · FY2005 · NS
NEURONAL RESPONSES TO AB-DERIVED ACTIVE LIGANDS
$201,157Evanston Hospital · P01 · FY2000 · AG
Heat Therapy versus Exercise Training in Hypertension
$201,002Christopher Todd Minson · University Of Oregon · R01 · FY2019 · HL
Chemotherapy for Huntington's Disease
$200,908Steven M Hersch · Massachusetts General Hospital · P01 · FY2007 · NS
Regulation of Sp1-mediated gene transcription in Huntington's Disease
$200,908Dimitri Krainc · Massachusetts General Hospital · P01 · FY2007 · NS
Parkinson's Disease Mouse Model with Mutant LRRK2
$200,900Christopher A Ross · Johns Hopkins University · R21 · FY2011 · NS
Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline?
$200,774Stewart F Graham · William Beaumont Hospital Research Inst · R33 · FY2023 · AG
CSF Tau Biomarker-guided Development of Hsp90 Inhibitors for Alzheimer's Disease
$200,752Yukari Perrella · Yuma Therapeutics Corporation · R41 · FY2012 · AG
T cells in the aging brain
$200,720Anne Brunet · Stanford University · R01 · FY2024 · AG
Microglial Activation and Neurodegeneration
$200,655University Of Nebraska Medical Center · P01 · FY2004 · NS
Microglial Activation and Neurodegeneration
$200,655University Of Nebraska Medical Center · P01 · FY2003 · NS
Integrating Genomic Signatures with Functional Analysis of DNA repair
$200,650Zachary David Nagel · Broad Institute, Inc. · R21 · FY2024 · ES
Mayo Clinic Center for Clinical and Translational Science (CCaTS)
$200,633Vesna D Garovic · Mayo Clinic Rochester · UL1 · FY2024 · TR
Small Molecule Neurotrophin Mimetics to Treat Huntington's Disease
$200,630Frank M Longo · Stanford University · R21 · FY2011 · NS
Is u-calpain a pathologic isoform?
$200,625James W Geddes · University Of Kentucky · P01 · FY2008 · NS
Molecular Origins of Neurodegeneration through Force Detangling of Toxic RNA
$200,597Sarah A Woodson · Johns Hopkins University · R21 · FY2024 · NS
Depressive symptoms in the pathogenesis of preclinical Alzheimer's Disease
$200,594Jennifer Rose Gatchel · Massachusetts General Hospital · K23 · FY2019 · AG
Targeting SNO-GAPDH in inflammatory neurodegeneration and mitochondrial injury
$200,560Michael D Kornberg · Johns Hopkins University · K08 · FY2020 · NS
Targeting SNO-GAPDH in inflammatory neurodegeneration and mitochondrial injury
$200,560Michael D Kornberg · Johns Hopkins University · K08 · FY2023 · NS
Targeting SNO-GAPDH in inflammatory neurodegeneration and mitochondrial injury
$200,560Michael D Kornberg · Johns Hopkins University · K08 · FY2022 · NS
Targeting SNO-GAPDH in inflammatory neurodegeneration and mitochondrial injury
$200,560Michael D Kornberg · Johns Hopkins University · K08 · FY2024 · NS
Targeting SNO-GAPDH in inflammatory neurodegeneration and mitochondrial injury
$200,560Michael D Kornberg · Johns Hopkins University · K08 · FY2021 · NS
Anti-viral Therapy in Alzheimer's Disease
$200,549Davangere P Devanand · Columbia University Health Sciences · R01 · FY2019 · AG